Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 6
Submit an article Journal homepage
2,543
Views
4
CrossRef citations to date
0
Altmetric
Coronavirus – Case Report

Miller-Fisher syndrome and Guillain–Barre syndrome overlap syndrome following inactivated COVID-19 vaccine: Case report and scope review

Hao Lianga Department of Acupuncture, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, ChinaView further author information
,
Yuanbo Caob Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, ChinaView further author information
,
Wei Zhongc Department of Rheumatology and Immunology, Affiliated Qiqihar Hospital, Southern Medical University, Qiqihar, ChinaView further author information
,
Zhenwang Maa Department of Acupuncture, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, ChinaView further author information
,
Jia Liud Institute for Brain Disorders, Beijing University of Chinese Medicine, Beijing, China;e Department of Neurology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7931-4288View further author information
ORCID Icon &
Hong Chenf Department of TCM Geriatric, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, China;g Department of TCM Geriatric, Southern Medical University, Guangzhou, ChinaCorrespondence[email protected]
View further author information
Article: 2125753 | Received 14 Aug 2022, Accepted 14 Sep 2022, Published online: 31 Oct 2022

References

  • Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barre syndrome. Lancet. 2021;397:1–5. doi:10.1016/S0140-6736(21)00517-1.
  • Sejvar JJ, Kohl KS, Gidudu J, Amato A, Bakshi N, Baxter R, Burwen DR, Cornblath DR, Cleerbout J, Edwards KM, et al. 2011. Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 29:599–612. doi:10.1016/j.vaccine.2010.06.003.
  • van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol. 2014;10:469–82. doi:10.1038/nrneurol.2014.121.
  • Yuki N, Kuwabara S. Axonal Guillain-Barre syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst. 2007;12:238–49. doi:10.1111/j.1529-8027.2007.00153.x.
  • Assiri SA, Althaqafi RMM, Alswat K, Alghamdi AA, Alomairi NE, Nemenqani DM, Ibrahim ZS, Elkady A. Post COVID-19 vaccination-associated neurological complications. Neuropsychiatr Dis Treat. 2022;18:137–54. doi:10.2147/NDT.S343438.
  • Dang YL, Bryson A. Miller-Fisher syndrome and Guillain-Barre syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination. BMJ Case Rep. 2021;14:e246701. doi:10.1136/bcr-2021-246701.
  • Nishiguchi Y, Matsuyama H, Maeda K, Shindo A, Tomimoto H. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination. BMC Neurol. 2021;21:452. doi:10.1186/s12883-021-02489-x.
  • Kim JE, Park J, Min YG, Hong YH, Song TJ. Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: disproportionality analysis using the World Health Organization pharmacovigilance database. J Peripher Nerv Syst. 2022;27:206–14. doi:10.1111/jns.12507.
  • Parida SP, Sahu DP, Singh AK, Alekhya G, Subba SH, Mishra A, Padhy BM, Patro BK. Adverse events following immunization of COVID-19 (Covaxin) vaccine at a tertiary care center of India. J Med Virol. 2022;94:2453–59. doi:10.1002/jmv.27655.
  • Tamborska AA, Singh B, Leonhard SE, Hodel EM, Stowe J, Watson-Fargie T, Fernandes PM, Themistocleous AC, Roelofs J, Brennan K, et al. 2022. Guillain-Barre syndrome following SARS-CoV-2 vaccination in the UK: a prospective surveillance study. BMJ Neurol Open. 4:e000309. doi:10.1136/bmjno-2022-000309.
  • Garcia-Grimshaw M, Michel-Chavez A, Vera-Zertuche JM, Galnares-Olalde JA, Hernandez-Vanegas LE, Figueroa-Cucurachi M, Paredes-Ceballos O, Reyes-Teran G, Carbajal-Sandoval G, Ceballos-Liceaga SE, et al. 2021. Guillain-Barre syndrome is infrequent among recipients of the BNT162b2 mRNA COVID-19 vaccine. Clin Immunol. 230:108818. doi:10.1016/j.clim.2021.108818.
  • Yamakawa M, Nakahara K, Nakanishi T, Nomura T, Ueda M. Miller Fisher syndrome following vaccination against SARS-CoV-2. Intern Med. 2022;61:1067–69. doi:10.2169/internalmedicine.8851-21.
  • Abicic A, Adamec I, Habek M. Miller Fisher syndrome following Pfizer COVID-19 vaccine. Neurol Sci. 2022;43:1495–97. doi:10.1007/s10072-021-05776-0.
  • Kim JE, Min YG, Shin JY, Kwon YN, Bae JS, Sung JJ, Hong YH. Guillain-Barre syndrome and variants following COVID-19 vaccination: report of 13 cases. Front Neurol. 2021;12:820723. doi:10.3389/fneur.2021.820723.
  • Kubota T, Hasegawa T, Ikeda K, Aoki M. Case report: isolated, unilateral oculomotor palsy with anti-GQ1b antibody following COVID-19 vaccination. F1000res. 2021;10:1142. doi:10.12688/f1000research.74299.1.
  • Siddiqi AR, Khan T, Tahir MJ, Asghar MS, Islam MS, Yousaf Z. Miller Fisher syndrome after COVID-19 vaccination: case report and review of literature. Medicine (Baltimore). 2022;101:e29333. doi:10.1097/MD.0000000000029333.
  • Michaelson NM, Lam T, Malhotra A, Schiff ND, MacGowan DJL. Miller Fisher syndrome presenting after a second dose of Pfizer-BioNtecH vaccination in a patient with resolved COVID-19: a case report. J Clin Neuromuscul Dis. 2021;23:113–15. doi:10.1097/CND.0000000000000376.
  • Chiba A, Kusunoki S, Obata H, Machinami R, Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barre syndrome: clinical and immunohistochemical studies. Neurology. 1993;43:1911–17. doi:10.1212/WNL.43.10.1911.
  • Salmon DA, Proschan M, Forshee R, Gargiullo P, Bleser W, Burwen DR, Cunningham F, Garman P, Greene SK, Lee GM, et al. 2013. Association between Guillain-Barre syndrome and influenza a (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet. 381:1461–68. doi:10.1016/S0140-6736(12)62189-8.
  • Prestel J, Volkers P, Mentzer D, Lehmann HC, Hartung HP, Keller-Stanislawski B; Group GBSSRisk of Guillain-Barre syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf. 2014;23:1192–204. doi:10.1002/pds.3638.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.